Based on the last Quarterly, a cap raise is not imminent and may not be necessary if their grant applications are successful:
"EMVision’s activities over the remainder of FY25 will be supported by further non-dilutive funding from the ASA grant program. The final ASA milestone payments are due on achievement of telemedicine and road/air integration activities ($400,000) and commencement of pilot studies of the First Responder device ($400,000).
With grant programs that have supported development and commercialisation of the emu™ Bedside Scanner reaching their conclusion, EMVision continues to actively pursue non-dilutive Federal and State funding opportunities to advance and accelerate other activities including the First Responder device".
EMV Price at posting:
$1.71 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)